186 related articles for article (PubMed ID: 37298606)
1. Diagnostic Utility of TSSC3 and RB1 Immunohistochemistry in Hydatidiform Mole.
Chia WK; Chia PY; Abdul Aziz NH; Shuib S; Mustangin M; Cheah YK; Khong TY; Wong YP; Tan GC
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298606
[TBL] [Abstract][Full Text] [Related]
2. Hydatidiform Moles: Ancillary Techniques to Refine Diagnosis.
Ronnett BM
Arch Pathol Lab Med; 2018 Dec; 142(12):1485-1502. PubMed ID: 30500280
[TBL] [Abstract][Full Text] [Related]
3. p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.
Lund H; Nielsen S; Grove A; Vyberg M; Sunde L
Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):694-701. PubMed ID: 31567274
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
[TBL] [Abstract][Full Text] [Related]
5. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M
Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM
Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308
[TBL] [Abstract][Full Text] [Related]
7. Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification.
Genest DR; Dorfman DM; Castrillon DH
J Reprod Med; 2002 May; 47(5):342-6. PubMed ID: 12063872
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of p57 immunohistochemistry and DNA ploidy analysis by fluorescence in situ hybridisation in hydatidiform moles.
Wong YP; Chia WK; Selimin A; Chia PY; Mustangin M; Shuib S; Khong TY; Tan GC
Malays J Pathol; 2021 Dec; 43(3):341-351. PubMed ID: 34958055
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2.
Castrillon DH; Sun D; Weremowicz S; Fisher RA; Crum CP; Genest DR
Am J Surg Pathol; 2001 Oct; 25(10):1225-30. PubMed ID: 11688455
[TBL] [Abstract][Full Text] [Related]
10. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case.
Fisher RA; Nucci MR; Thaker HM; Weremowicz S; Genest DR; Castrillon DH
Mod Pathol; 2004 Sep; 17(9):1155-60. PubMed ID: 15314611
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Androgenetic Complete Hydatidiform Moles with p57
Li MW; Li F; Cheng J; Wang F; Zhou P
Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065
[TBL] [Abstract][Full Text] [Related]
12. Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry.
Crisp H; Burton JL; Stewart R; Wells M
Histopathology; 2003 Oct; 43(4):363-73. PubMed ID: 14511255
[TBL] [Abstract][Full Text] [Related]
13. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
14. "While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review.
Giacometti C; Bellan E; Ambrosi A; Dei Tos AP; Cassaro M; Ludwig K
Placenta; 2021 Dec; 116():31-37. PubMed ID: 33714612
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole.
Thaker HM; Berlin A; Tycko B; Goldstein DP; Berkowitz RS; Castrillon DH; Genest DR
J Reprod Med; 2004 Aug; 49(8):630-6. PubMed ID: 15457853
[TBL] [Abstract][Full Text] [Related]
16. [Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
Dong Y; Zhang S; Wang ML; Guo H; Zhang Y; Wang Y; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):194-8. PubMed ID: 21503111
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of glycophorin-A in comparison with P57 immunohistochemical staining method in differentiating complete and partial molar pregnancies.
Nili F; Babazadeh S; Sarmadi S; Ameli F; Saffar H
Ann Diagn Pathol; 2021 Aug; 53():151769. PubMed ID: 34146830
[TBL] [Abstract][Full Text] [Related]
18. Tetraploid partial hydatidiform mole: a case report and review of the literature.
Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM
Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726
[TBL] [Abstract][Full Text] [Related]
19. Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.
Xing D; Miller K; Beierl K; Ronnett BM
Am J Surg Pathol; 2022 Jan; 46(1):18-32. PubMed ID: 34074808
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis between complete and partial mole by TSSC3 antibody completely correlates to DNA diagnosis.
Kato H; Matsuda T; Hirakawa T; Ueda K; Inoue T; Miyanari Y; Asanoma K; Nakano H; Wake N
Diagn Mol Pathol; 2005 Sep; 14(3):164-9. PubMed ID: 16106198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
